Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Current Assets (2019 - 2026)

Viatris (VTRS) posted Current Assets of $10.1 billion for Q2 2026, down 7.89% on a QoQ basis from $10.9 billion in Q1 2026, and up 2.88% year-over-year from $9.8 billion in Q2 2025.

Analysis

Viatris (VTRS) Current Assets (2019 - 2026) Analysis & Trends

Viatris has reported Current Assets for 8 years, with the latest figure at $10.1 billion in Q2 2026.

  • On a quarterly basis, Current Assets rose 2.88% year-over-year to $10.1 billion in Q2 2026; TTM through Jun 2026 was $10.1 billion, a 2.88% increase from a year earlier, with the FY2025 full-year figure at $9.8 billion, up 2.82% from the prior year.
  • Current Assets was $10.1 billion for Q2 2026 at Viatris, down from $10.9 billion in the prior quarter.
  • The five-year high for Current Assets was $13.0 billion in Q4 2023, with the low at $9.5 billion in Q4 2024.
  • Average Current Assets over 5 years is $10.7 billion, with a median of $10.6 billion recorded in 2022.
  • The largest YoY upside for Current Assets was 34.2% in 2024 against a maximum downside of 26.63% in 2024.
  • Over 5 years, Current Assets stood at $10.6 billion in 2022, then gained by 22.01% to $13.0 billion in 2023, then retreated by 26.63% to $9.5 billion in 2024, then grew by 2.82% to $9.8 billion in 2025, then gained by 2.72% to $10.1 billion in 2026.
  • The last three Current Assets figures came in at $10.1 billion (Q2 2026), $10.9 billion (Q1 2026), and $9.8 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 13.76 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 10.06 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 3.16 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 1.95 Bn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 6.52 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 544.97 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 825.43 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 630.95 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 72.50 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 6.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.06 Bn
Mar 31, 2026 10.92 Bn
Dec 31, 2025 9.79 Bn
Sep 30, 2025 9.95 Bn
Jun 30, 2025 9.77 Bn
Mar 31, 2025 9.62 Bn
Dec 31, 2024 9.52 Bn
Sep 30, 2024 11.31 Bn
Jun 30, 2024 11.79 Bn
Mar 31, 2024 12.92 Bn
Dec 31, 2023 12.98 Bn
Sep 30, 2023 10.93 Bn
Jun 30, 2023 9.78 Bn
Mar 31, 2023 9.63 Bn
Dec 31, 2022 10.64 Bn
Sep 30, 2022 10.49 Bn
Jun 30, 2022 11.18 Bn
Mar 31, 2022 11.74 Bn
Dec 31, 2021 10.90 Bn
Sep 30, 2021 11.31 Bn